EXEL
Exelixis, Inc. · Healthcare
EVP, Research, Development Dana Aftab sold $2.1M of Exelixis, Inc.
Sold$2,132,351
$44.50Price
47,918Shares
−7%Stake
What EXEL did after the filing
- The stock from Thu, Feb 26 close, $44.28
- 0.0%
- S&P 500, same days
- −1.4%
Measured over 30 trading days, to the Apr 10 close.
Traded Tue, Feb 24. Filed Thu, Feb 26, 1:41 PM ET, during the session. Returns use the Feb 26 close and the Apr 10 close. Not investment advice.